Deerfield Healthcare Innovations Fund, L.P. has an estimated net worth of $2.24 Billion. This is based on reported shares across multiple companies, which include Editas Medicine, Inc., Nuvalent, Inc., Mirum Pharmaceuticals, Inc., GRAYBUG VISION, INC., Larimar Therapeutics, Inc., Homology Medicines, Inc., and Oncorus, Inc..

2020 was Deerfield Healthcare Innovations Fund, L.P.'s most active year for acquiring shares with 14 total transactions. Deerfield Healthcare Innovations Fund, L.P.'s most active month to acquire stocks was the month of January. 2022 was Deerfield Healthcare Innovations Fund, L.P.'s most active year for disposing of shares, totalling 39 transactions. Deerfield Healthcare Innovations Fund, L.P.'s most active month to dispose stocks was the month of November. 2020 saw Deerfield Healthcare Innovations Fund, L.P. paying a total of $40,000,000.00 for 8,130,683 shares, this is the most they've acquired in one year. In 2024 Deerfield Healthcare Innovations Fund, L.P. cashed out on 2,000,000 shares for a total of $195,500,000.00, their largest year based on trade value.